Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
RMD Open|October 25, 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension studyMaya H Buch, Daniel Aletaha, Bernard G Combe, et al.
Cell Communication and Signaling : CCS|February 2, 2024
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activityLuna Dillemans, Karen Yu, Alexandra De Zutter, et al.
Frontiers in Immunology|December 16, 2021
Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial FluidsBernard Grillet, Karen Yu, Estefania Ugarte-Berzal, et al.
The New England Journal of Medicine|April 26, 2023
<i>TET2</i>-Driver and <i>NLRC4</i>-Passenger Variants in Adult-Onset AutoinflammationEllen De Langhe, Sien Van Loo, Bert Malengier-Devlies, et al.
Clinical Chemistry|March 7, 2009
Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigenKarolien Van den Bergh, Herbert Hooijkaas, Daniel Blockmans, et al.
Frontiers in Immunology|July 26, 2023
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cellsKris Covens, Bert Verbinnen, Britt G de Jong, et al.
Annals of the Rheumatic Diseases|November 14, 2022
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, et al.
Arthritis Care & Research|October 20, 2025
The Patient-Reported Outcomes Measurement Information System scale v1.2 Global Health (PROMIS-GH) is useful to assess mental and physical health in individuals with chronic musculoskeletal pain, rheumatoid arthritis, hip/knee osteoarthritis, or people undergoing physiotherapy: Results of factor and item response theory analysesEmanuele M Giusti, Leonardo Pellicciari, Martine H P Crins, et al.
Annals of the Rheumatic Diseases|November 11, 2022
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|November 21, 2022
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisSytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
RMD Open|October 25, 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension studyMaya H Buch, Daniel Aletaha, Bernard G Combe, et al.
Cell Communication and Signaling : CCS|February 2, 2024
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activityLuna Dillemans, Karen Yu, Alexandra De Zutter, et al.
Frontiers in Immunology|December 16, 2021
Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial FluidsBernard Grillet, Karen Yu, Estefania Ugarte-Berzal, et al.
The New England Journal of Medicine|April 26, 2023
<i>TET2</i>-Driver and <i>NLRC4</i>-Passenger Variants in Adult-Onset AutoinflammationEllen De Langhe, Sien Van Loo, Bert Malengier-Devlies, et al.
Clinical Chemistry|March 7, 2009
Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigenKarolien Van den Bergh, Herbert Hooijkaas, Daniel Blockmans, et al.
Frontiers in Immunology|July 26, 2023
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cellsKris Covens, Bert Verbinnen, Britt G de Jong, et al.
Annals of the Rheumatic Diseases|November 14, 2022
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, et al.
Arthritis Care & Research|October 20, 2025
The Patient-Reported Outcomes Measurement Information System scale v1.2 Global Health (PROMIS-GH) is useful to assess mental and physical health in individuals with chronic musculoskeletal pain, rheumatoid arthritis, hip/knee osteoarthritis, or people undergoing physiotherapy: Results of factor and item response theory analysesEmanuele M Giusti, Leonardo Pellicciari, Martine H P Crins, et al.
Annals of the Rheumatic Diseases|November 11, 2022
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases|November 21, 2022
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritisSytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, et al.
Pageof 16